Large-scale testing (Phase 3)Not Yet RecruitingNCT07770984What this trial is testingTreatment of CKD Patients With HCVWho this might be right forHCV Infection ( Genotype 4) in CKD Patients Tanta University 50
Large-scale testing (Phase 3)Study completedNCT02642432What this trial is testingEvaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated CirrhosisWho this might be right forHepatitis C Virus InfectionChronic Hepatitis CCompensated Cirrhosis AbbVie 146
Testing effectiveness (Phase 2)Study completedNCT01713283What this trial is testingSofosbuvir Plus Ribavirin in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) InfectionWho this might be right forHepatitis C Virus Gilead Sciences 60
Post-approval studies (Phase 4)Study completedNCT00412334What this trial is testingSYREN Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin) in Non-Responder Patients With Chronic Hepatitis C (CHC) Genotype 1.Who this might be right forHepatitis C, Chronic Hoffmann-La Roche 104
Post-approval studies (Phase 4)Ended earlyNCT01606800What this trial is testingEfficacy and Safety of Short Course Therapy With Peginterferon Alpha-2b (PEG-IFN Alfa-2b) and Ribavirin (RBV) for Chronic Hepatitis C (Genotype 4) Participants Achieving a Rapid Virological Response at Week 4 of Treatment (MK-8908B-059)Who this might be right forHepatitis C, Chronic Merck Sharp & Dohme LLC 45
Large-scale testing (Phase 3)Study completedNCT02483156What this trial is testingRandomized, Open-Label, Study to Evaluate the Safety and Efficacy of Sofosbuvir Tablet Plus Ribavirin Tablet (Part A) Versus Single Dose (2 Tablets) of EHCV Containing Sofosbuvir, Ribavirin, and Natural Anti-hemolytic (B) in Egyptian Adults With Chronic Genotype 4 HCV InfectionWho this might be right forHepatitis c Egyptian Liver Hospital 80
Testing effectiveness (Phase 2)Study completedNCT01858766What this trial is testingSafety and Efficacy of Sofosbuvir + Velpatasvir With or Without Ribavirin in Treatment-Naive Adults With Chronic HCV InfectionWho this might be right forHepatitis C Gilead Sciences 379
Testing effectiveness (Phase 2)Study completedNCT03036839What this trial is testingLedipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Stage Renal DiseaseWho this might be right forHepatitis C Virus Infection Gilead Sciences 95
Large-scale testing (Phase 3)UnknownNCT01653236What this trial is testingBoceprevir With Peginterferon Alfa-2b and Ribavirin in the Treatment-naive Patients Infected With Genotype 4 Chronic Hepatitis C InfectionWho this might be right forGenotype 4 Chronic Hepatitis C Infection Theodor Bilharz Research Institute 40
Large-scale testing (Phase 3)Study completedNCT02073656What this trial is testingEfficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infectionWho this might be right forHepatitis C VirusHIV Gilead Sciences 335
Large-scale testing (Phase 3)Study completedNCT02487199What this trial is testingOmbitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Kidney Impairment or End Stage Kidney DiseaseWho this might be right forHepatitis C Virus (HCV) AbbVie 18
Post-approval studies (Phase 4)Study completedNCT00502099What this trial is testingComparison of Pegasys Versus Peg-Intron for Treatment of Chronic Hepatitis C Genotype 4Who this might be right forHepatitis C Amr Hafez 217
Large-scale testing (Phase 3)Ended earlyNCT02504099What this trial is testingEvaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular CarcinomaWho this might be right forChronic Hepatitis C Infection AbbVie 3
Testing effectiveness (Phase 2)Study completedNCT04385407What this trial is testingSofosbuvir With Ribavirin or Simeprevir With HCV GT4 Egyptian PatientsWho this might be right forChronic Hepatitis C Virus Infection Beni-Suef University 203
Large-scale testing (Phase 3)UnknownNCT01655966What this trial is testingVitamin D as an add-on Therapy With Pegylated Interferon and Ribavirin for Chronic Hepatitis cWho this might be right forChronic Hepatitis c Cairo University 80
Testing effectiveness (Phase 2)Study completedNCT02350569What this trial is testingSafety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation SettingWho this might be right forHepatitis C Virus Infection Gilead Sciences 17
Large-scale testing (Phase 3)WithdrawnNCT02099604What this trial is testingEfficacy and Safety of the Combination Vitamin D With Standard of Care in Egyptian Patients With Untreated Chronic Hepatitis CWho this might be right forChronic Hepatitis C ANRS, Emerging Infectious Diseases
Large-scale testing (Phase 3)Study completedNCT02243293What this trial is testingEvaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 InfectionWho this might be right forChronic Hepatitis CHepatitis C Virus AbbVie 694
Post-approval studies (Phase 4)UnknownNCT02950870What this trial is testingEfficacy Study to Evaluate the Effect of New Antiviral Drugs on HCV Infection.Who this might be right forChronic Hepatitis, C Virus University of Modena and Reggio Emilia 75
Testing effectiveness (Phase 2)Study completedNCT02765490What this trial is testingEfficacy and Safety of Combinations of AL-335, Odalasvir (ODV) and Simeprevir (SMV) in the Treatment of Chronic Hepatitis C InfectionWho this might be right forHepatitis C, Chronic Janssen Research & Development, LLC 365